Clinical Trial

Clinical Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HSK31858 in Healthy Subjects

Enrolling by Invitation Phase 1
View on ClinicalTrials.gov →
Summary
This is a single-center, open-label, two-period, fixed-sequence clinical study to evaluate the effect of Itraconazole on the pharmacokinetics of HSK31858 in healthy subjects
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-14.
Trial Details
NCT Number NCT07134465
Lead Sponsor Haisco Pharmaceutical Group Co., Ltd.
Conditions Healthy Subjects
Enrollment 24 participants
Start Date 2025-08-11
Primary Completion 2026-11-30 (estimated)
Study Completion 2026-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-31